Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gansu Pharmaceutical Group is a large-scale state-owned enterprise headquartered in Lanzhou, China, dedicated to the integration of pharmaceutical research, manufacturing, and distribution. The group serves as a central platform for the modernization of Traditional Chinese Medicine (TCM) in the Gansu region, utilizing local herbal resources to produce high-quality patent medicines. Its operations span the entire industrial chain, including the production of chemical drugs, medical devices, and the management of extensive pharmaceutical logistics networks. By consolidating provincial healthcare assets, the group aims to enhance regional drug supply security and promote the internationalization of TCM. The company's portfolio includes well-known brands and essential medicines used across various therapeutic areas such as respiratory, cardiovascular, and digestive health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gansu Pharmaceutical Group.